ADHD, ADD
3
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Written Decision Aid
Research Leaders
5 sponsors active, led by St. Antonius Hospital
Related Conditions
Often studied with 15 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
33%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Empowering Caregivers in ADHD Treatment: Standard Care Vs. Decision Aid, Coaching, and AI Support
The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
Research Network
Common Treatments
- Written Decision Aid1
- Aidriven Support1
- Decision Aid Decision Coaching1
- Communication Strategy For Side Effect Counseling In Adhd Treatment1
- Dexmethylphenidate Hydrochloride1
Active Sponsors
- St. Antonius Hospital1
- Ariel University1
- Novartis1
- University of Ottawa1
- Tel Aviv University1
Top Investigators
St. Antonius Hospital
'MyHealthAid' research lab - Ariel University
Related Conditions
- Adhd2
- Attention Deficit Disorder Add1
- Hyperactivity Disorder1
- Inattention1
- Adhd Predominantly Hyperactive Impulsive1